Home › NDC Lookup › Ingredients › Salicylic Acid 45% › 87204-0212-01
QKEKL WART REMOVER Salicylic Acid 45% .45 mg/30mL Liquid, 30 mL — NDC 87204-0212-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

QKEKL WART REMOVER Salicylic Acid 45% .45 mg/30mL Liquid, 30 mL — NDC 87204-212-01 (Billing 87204-0212-01)

by Guangzhou Huixue Biotechnology Co., Ltd. · 30 mL in 1 BOTTLE, PLASTIC

This is a package of 30 mL of QKEKL WART REMOVER Salicylic Acid 45% .45 mg/30mL Liquid from Guangzhou Huixue Biotechnology Co., Ltd., marketed since Sep 2026 and currently FDA-listed, this package's marketing is listed to end Sep 2027. It is this product's only package size.

NDC 87204-0212-01
🏷️ FDA NDC (as labeled) 87204-212-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87204-212-01
Product NDC 87204-212
11-digit billing NDC 87204021201
UNII O414PZ4LPZ
Application # M028
SPL Set ID 5aeeafa6-4167-dcc3-e063-6294a90a26bb
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-09-05
Marketing end 2027-09-11
Route TOPICAL
Dosage form LIQUID
Substance SALICYLIC ACID
Why two NDCs? The FDA registers this code as 87204-212-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87204-0212-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

QKEKL Wart Remover is a topical liquid containing salicylic acid, marketed as an over-the-counter monograph product. Salicylic acid is commonly used in wart removal products to help break down and soften the outer layers of skin on warts. This product is applied directly to the affected skin area. Salicylic acid functions by causing the top layer of skin cells to shed, which over time may help reduce wart size.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87204-0212-01 You're viewing this Main listing 30 mL in 1 BOTTLE, PLASTIC 2026-09-05 Sep 11, 2027 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Qkekl Wart Remover .45 mg/30mLthis 87204-0212-01 Guangzhou 30 ml — — FDA listed —
Wopres Wart Remover .45 mg/30mL 87204-0203-01 Guangzhou 30 ml — — FDA listed —
Wopres Wart Remover .45 mg/30mL 87204-0204-01 Guangzhou 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Sep 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 344S277G0Z
    Allantoin is a naturally derived compound that helps soften and soothe skin. In medicines, it works as a skin-conditioning agent and may help support wound healing and reduce irritation in topical formulations.
  • UNII 24WE03BX2T
    Levomenol is a naturally derived alcohol compound used as a skin-conditioning and anti-inflammatory agent in topical formulations. It helps soothe and protect the skin while improving product texture and absorption.
  • UNII M89NIB437X
    Borneol is a waxy, plant-derived alcohol obtained from camphor trees or made synthetically. It's used in medicines as a flavoring agent and penetration enhancer to improve how active ingredients are absorbed.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesWater, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Angustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGuangzhou Huixue Biotechnology Co., Ltd.
FDA applicationM028 (OTC MONOGRAPH DRUG)
Labeler code87204
First marketedSep 2026
Product typeHuman Otc Drug
Portfolio46 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 94 words ▾

For the removal of warts includinn nlantar warts flat warts common warts, corns, and calluses.1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional) 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers complete ly.

Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth 4.

More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.

⏱️ Dosage and Administration 54 words ▾

1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth.

⚠️ Warnings 85 words ▾

For external use only. .Flammable Keep away from fire and flame. ·Keep out of reach of children. .Avoid contact with eyes, in case of contact, flush eyes with plenty c cool water. .Do not swallow, if swallowed, seek medical attention or contact a Poisor Control Center (1-800-222-1222) immediately.Children should use this product under adult supervision. .Avoid prolonged exposure to air during use as the substance may dissolve and crystallize easily. .Recap immediately after each use, Do not use if the cap is broken or missing.

🧪 Active Ingredient 3 words ▾

Salicylic Acid 45%

🧪 Inactive Ingredients 35 words ▾

Water, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Angustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract.

🎯 Purpose 15 words ▾

For the removal of warts includinn nlantar warts flat warts common warts, corns, and calluses.

📄 Do Not Use 67 words ▾

On broken skin or the area around the eyes. On irritated skin or on any area that is infected or reddened.If you are allergic to any ingredient .On moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes. •If you have diabetes or poor blood circulation. . If you are pregnant or breastfeeding unless directed by a healthcare practitioner.

📄 When Using This Product 79 words ▾

1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth. 4. More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.

📄 Stop Use and Ask a Doctor If 25 words ▾

You become pregnant or are trying to become pregnant while using this nroduct .Irritation or redness occurs, worsens or does not imnrnve with continued use.

📄 Keep Out of Reach of Children 10 words ▾

Store at room temperature. Avoid excessive heat above 37°℃ (99°F).

📄 Package Label / Principal Display Panel 6 words ▾

QKEKL WART REMOVER QKEKL WART REMOVER

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Guangzhou Huixue Biotechnology Co., Ltd. has reported a marketing end date of 2027-09-11, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Guangzhou Huixue Biotechnology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87204-0207-01 · Guangzhou 87204-0248-01 · Guangzhou →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.